Legal & General Group’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-32,260
| Closed | -$195K | – | 3380 |
|
|
2019
Q4 | $195K | Hold |
32,260
| – | – | ﹤0.01% | 2408 |
|
|
2019
Q3 | $116K | Buy |
32,260
+6,985
| +28% | +$26.9K | ﹤0.01% | 2486 |
|
|
2019
Q2 | $68K | Hold |
25,275
| – | – | ﹤0.01% | 2663 |
|
|
2019
Q1 | $75K | Hold |
25,275
| – | – | ﹤0.01% | 2583 |
|
|
2018
Q4 | $40K | Buy |
25,275
+3,918
| +18% | +$11.1K | ﹤0.01% | 2781 |
|
|
2018
Q3 | $79K | Buy |
21,357
+2,454
| +13% | +$7.31K | ﹤0.01% | 2577 |
|
|
2018
Q2 | $53K | Sell |
18,903
-5,084
| -21% | -$17.3K | ﹤0.01% | 2725 |
|
|
2018
Q1 | $89K | Sell |
23,987
-22,358
| -48% | -$73.2K | ﹤0.01% | 2509 |
|
|
2017
Q4 | $134K | Hold |
46,345
| – | – | ﹤0.01% | 2464 |
|
|
2017
Q3 | $207K | Buy |
46,345
+3,445
| +8% | +$15.3K | ﹤0.01% | 2336 |
|
|
2017
Q2 | $196K | Buy |
42,900
+15,000
| +54% | +$60.3K | ﹤0.01% | 2304 |
|
|
2017
Q1 | $119K | Sell |
27,900
-427
| -2% | -$1.77K | ﹤0.01% | 2459 |
|
|
2016
Q4 | $117K | Buy |
28,327
+11,166
| +65% | +$59.4K | ﹤0.01% | 2462 |
|
|
2016
Q3 | $136K | Sell |
17,161
-849
| -5% | -$7.22K | ﹤0.01% | 2134 |
|
|
2016
Q2 | $141K | Hold |
18,010
| – | – | ﹤0.01% | 1920 |
|
|
2016
Q1 | $140K | Buy |
18,010
+2,443
| +16% | +$17.9K | ﹤0.01% | 1871 |
|
|
2015
Q4 | $166K | Hold |
15,567
| – | – | ﹤0.01% | 1822 |
|
|
2015
Q3 | $103K | Buy |
15,567
+1,066
| +7% | +$8.69K | ﹤0.01% | 2024 |
|
|
2015
Q2 | $124K | Hold |
14,501
| – | – | ﹤0.01% | 1971 |
|
|
2015
Q1 | $147K | Hold |
14,501
| – | – | ﹤0.01% | 1813 |
|
|
2014
Q4 | $181K | Sell |
14,501
-458
| -3% | -$5.59K | ﹤0.01% | 1620 |
|
|
2014
Q3 | $156K | Buy |
+14,959
| New | +$139K | ﹤0.01% | 1629 |
|
Legal & General Group's ACHN Position: Q1 2020 in Review
Legal & General Group sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 32,260 shares — an estimated $195K sold.
Legal & General Group first reported a position in ACHN in Q3 2014 and held it in 22 quarters. The position peaked at $207K in Q3 2017. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Legal & General Group reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Legal & General Group sold 32,260 Achillion Pharmaceuticals shares in Q1 2020, an estimated $195K.
- Legal & General Group first reported a position in Achillion Pharmaceuticals in Q3 2014 and held it in 22 quarters.
- Legal & General Group's Achillion Pharmaceuticals position peaked at $207K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Legal & General Group's 13F filing for Q1 2020, filed 14 May 2020.